Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ANIDULAFUNGIN Cause Acute hepatic failure? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Acute hepatic failure have been filed in association with ANIDULAFUNGIN (ERAXIS). This represents 1.1% of all adverse event reports for ANIDULAFUNGIN.

8
Reports of Acute hepatic failure with ANIDULAFUNGIN
1.1%
of all ANIDULAFUNGIN reports
7
Deaths
3
Hospitalizations

How Dangerous Is Acute hepatic failure From ANIDULAFUNGIN?

Of the 8 reports, 7 (87.5%) resulted in death, 3 (37.5%) required hospitalization.

Is Acute hepatic failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ANIDULAFUNGIN. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does ANIDULAFUNGIN Cause?

Drug ineffective (234) Multiple organ dysfunction syndrome (108) Off label use (85) Candida infection (61) Death (57) Neutropenia (53) Pneumonia (49) Septic shock (45) Sepsis (42) Condition aggravated (37)

What Other Drugs Cause Acute hepatic failure?

ACETAMINOPHEN (3,141) PREDNISONE (439) IBUPROFEN (412) RITUXIMAB (412) CYCLOPHOSPHAMIDE (411) DOXORUBICIN (385) VINCRISTINE (346) PREDNISOLONE (301) METHOTREXATE (285) DEXAMETHASONE (249)

Which ANIDULAFUNGIN Alternatives Have Lower Acute hepatic failure Risk?

ANIDULAFUNGIN vs ANIFROLUMAB ANIDULAFUNGIN vs ANIFROLUMAB-FNIA ANIDULAFUNGIN vs ANTHOXANTHUM ODORATUM POLLEN\DACTYLIS GLOMERATA POLLEN\LOLIUM PERENNE POLLEN\PHLEUM PRATENSE POLLEN\POA PRATENSIS POLLEN ANIDULAFUNGIN vs ANTI-INHIBITOR COAGULANT COMPLEX ANIDULAFUNGIN vs ANTIHEMOPHILIC FACTOR HUMAN

Related Pages

ANIDULAFUNGIN Full Profile All Acute hepatic failure Reports All Drugs Causing Acute hepatic failure ANIDULAFUNGIN Demographics